DTRE vs. THNR ETF Comparison
Comparison of First Trust Alerian Disruptive Technology Real Estate ETF (DTRE) to Amplify Weight Loss Drug & Treatment ETF (THNR)
DTRE
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE Description
First Trust Alerian Disruptive Technology Real Estate ETF is an exchange traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets. It invests in stocks of companies operating across real estate sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the Alerian Disruptive Technology Real Estate Index, by using full replication technique. First Trust Alerian Disruptive Technology Real Estate ETF was formed on August 27, 2007 and is domiciled in the United States.
Grade (RS Rating)
Last Trade
$38.47
Average Daily Volume
1,355
9
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.27
Average Daily Volume
10,610
7
Performance
Period | DTRE | THNR |
---|---|---|
30 Days | -0.16% | 2.35% |
60 Days | 4.34% | |
90 Days | -3.29% | |
12 Months | -3.43% |
0 Overlapping Holdings
Symbol | Grade | Weight in DTRE | Weight in THNR | Overlap |
---|
DTRE: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords